Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Rapidly taking patients off opioids might not be a good idea, experts say

Forcing patients off opioid painkillers could sometimes do more harm than good, international medical experts warn in an open letter to health authorities.

Read More »

FDA panel backs prescribing overdose reversal drug with opioids

An advisory panel to the U.S. Food and Drug Administration narrowly recommended prescribing the opioid overdose reversal drug naloxone along with addictive painkillers.

Read More »

FDA declines to approve Mallinckrodt’s abuse-deterrent opioid painkiller

The U.S. Food and Drug Administration declined to approve an abuse-deterrent version of Mallinckrodt Plc’s opioid painkiller Roxicodone, saying some parts of the company’s application need further evaluation.

Read More »

FDA staff says AcelRx opioid painkiller is not better than rivals

AcelRx Pharmaceuticals Inc.’s opioid painkiller offers no apparent advantage to currently available therapies, staff reviewers of the U.S. Food and Administration said.

Read More »

Bayer Cutting More Than 200 Jobs in San Francisco Bay Area

German company Bayer AG is laying off 227 staffers at the company’s manufacturing plant in Berkeley, California. Most of the cuts took place on October 3, 2018.

Read More »

Orexo soars after winning opioid drug appeal against Teva

A U.S. appeals court revived Swedish pharmaceutical company Orexo AB’s lawsuit accusing a unit of Israel’s Teva Pharmaceutical Industries Ltd. of infringing a patent for the opioid addiction drug Zubsolv.

Read More »

Maryland charges Insys with engaging in deceptive opioid scheme

Maryland charged Insys Therapeutics Inc. with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.

Read More »

Emergent BioSolutions to buy Narcan maker Adapt Pharma

Emergent BioSolutions will buy privately held Adapt Pharma, beefing up its portfolio with Narcan, the only FDA-approved needle-free emergency opioid overdose treatment.

Read More »

New York sues OxyContin maker Purdue Pharma

New York state sued Purdue Pharma LP, accusing the OxyContin maker of widespread fraud and deception in the marketing of opioids, and contributing to a nationwide epidemic.

Read More »

Opioids no better than NSAIDs for chronic back or arthritis pain

Acetaminophen, ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) are better than opioids at easing the intensity of chronic pain in the back, knees or hips, a U.S. experiment suggests.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom